| Product NDC: | 0409-3414 |
| Proprietary Name: | Metoclopramide |
| Non Proprietary Name: | METOCLOPRAMIDE HYDROCHLORIDE |
| Active Ingredient(s): | 5 mg/mL & nbsp; METOCLOPRAMIDE HYDROCHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-3414 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073118 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19910117 |
| Package NDC: | 0409-3414-01 |
| Package Description: | 25 VIAL in 1 TRAY (0409-3414-01) > 2 mL in 1 VIAL |
| NDC Code | 0409-3414-01 |
| Proprietary Name | Metoclopramide |
| Package Description | 25 VIAL in 1 TRAY (0409-3414-01) > 2 mL in 1 VIAL |
| Product NDC | 0409-3414 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19910117 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |